Hyperviscosity syndrome in hematological diseases and therapeutic apheresis.
The hyperviscosity syndrome classified into pleiocytosic, sclerotic and sieric syndromes according to the blood components involved are characterized by a different degree of clinical signs and symptoms related to rheological modification of blood. Therapeutic management of these syndromes is complex and the choice of apheresis treatment is generally restricted to emergency episodes in order to overcome the acute phase and to reverse the symptoms until definitive therapy is effective.
Accorsi
P
P
Department of Transfusion Medicine, Spirito Santo Civic Hospital, Pescara--Italy. patriziaaccorsi@virgilio.it
Passeri
C
C
Onofrillo
D
D
Iacone
A
A
D001809:Blood Viscosity; D002986:Clinical Trials as Topic; D006402:Hematologic Diseases / Q000097:blood / Q000628:therapy*; D006440:Hemofiltration / Q000379:methods*; D006801:Humans; D010956:Plasmapheresis / Q000379:methods*; D010818:Practice Patterns, Physicians'; D012598:Sclerosis / Q000628:therapy*; D013577:Syndrome; D016896:Treatment Outcome